Twist1 is a potential prognostic marker for colorectal cancer and associated with chemoresistance.

about

Twist1 is a potential prognostic marker for colorectal cancer and associated with chemoresistance.

Item

http://www.wikidata.org/entity/Q35929842

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Twist1 is a potential prognost ...... sociated with chemoresistance.

@ast

Twist1 is a potential prognost ...... sociated with chemoresistance.

@en

type

Item

label

Twist1 is a potential prognost ...... sociated with chemoresistance.

@ast

Twist1 is a potential prognost ...... sociated with chemoresistance.

@en

prefLabel

Twist1 is a potential prognost ...... sociated with chemoresistance.

@ast

Twist1 is a potential prognost ...... sociated with chemoresistance.

@en

P1476

Twist1 is a potential prognost ...... sociated with chemoresistance.

@en

P2093

Chang-Chun Liu

http://www.w3.org/2001/XMLSchema#string

Da-Jian Zhu

http://www.w3.org/2001/XMLSchema#string

Jia-Zhi Wang

http://www.w3.org/2001/XMLSchema#string

Man-Zhao Ouyang

http://www.w3.org/2001/XMLSchema#string

Qiang Zhong

http://www.w3.org/2001/XMLSchema#string

Wei-Jie Zhang

http://www.w3.org/2001/XMLSchema#string

Xiao-Wu Chen

http://www.w3.org/2001/XMLSchema#string

P2860

Hallmarks of Cancer: The Next Generation

Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis

TWIST1 is expressed in colorectal carcinomas and predicts patient survival

Adverse event profiles of 5-fluorouracil and capecitabine: data mining of the public version of the FDA Adverse Event Reporting System, AERS, and reproducibility of clinical observations.

Twist expression promotes migration and invasion in hepatocellular carcinoma.

Alterations of microRNAs and their targets are associated with acquired resistance of MCF-7 breast cancer cells to cisplatin.

Colorectal cancer statistics, 2014.

Tumor metastasis: a new twist on epithelial-mesenchymal transitions.

Twist induces an epithelial-mesenchymal transition to facilitate tumor metastasis.

Silencing of Twist1 sensitizes NSCLC cells to cisplatin via AMPK-activated mTOR inhibition.

P304

2000-2011

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-05-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26269759

http://www.w3.org/2001/XMLSchema#string

P921

colorectal cancer

P932

4529619

http://www.w3.org/2001/XMLSchema#string